Greenberg Traurig, LLP
Compositions and methods for treating hemoglobinopathies
The present invention features compositions and methods for editing deleterious mutations associated with hemoglobinopathies, such as sickle cell disease (SCD). In particular embodiments, the invention provides methods for correcting mutations in a beta globin polynucleotide using modified adenosine base editors termed “ABE8” having unprecedented levels (e.g., >60-70%) of efficiency.
Beam Therapeutics Inc.
A C C A C C A C C A C C A C C A C A C A C C C
A61P C12N C07K A61K C12N C12N A61K C07K C12N A61K C12N C12N A61K C07K C12N A61K C12N A61K C12Y A61P C12N C12N C07K
inventional additional inventional inventional additional inventional inventional additional additional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional additional additional
Nicole Bernd Yi Ian David A. Michael Seung-Joo
Gaudelli Zetsche Yu Slaymaker Born Packer Lee